Trialbee CEO Matt Walz Named to PharmaVoice100 for Innovation in Clinical Research
Trialbee CEO Matt Walz has been named to the 2022 PharmaVoice 100 an annual list that recognizes the most inspiring people in the life-sciences industry for his work to increase access, diversity,
Source: finanznachrichten.de